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ABSTRACT

Recently, nanoparticles have become an origin of exploration in the chemistry field due to their unique
medical uses. The current drug delivery models of nanoparticles often include a metal base with a drug
conjugated to its surface. However this raises concerns regarding toxicity. A novel approach to solving
this dilemma is the development of nanosized biocompatible polymer-based micelles, created from PEGPCL-PEG triblock polymer, and formed around a drug of choice. The goal is to create a drug carrier
nanoparticle system that is labile at a specific intracellular pH, without undue toxicity to the cell. This
creates a drug-loaded nanoparticle that dissociates when exposed to a pH of 5.4, thus releasing the drug
at the targeted location in the cell, the late endosome. Using polymer micelles as a drug-carrier allows
scientists to control the destination of the drug, while creating stand-alone units that can be combined to
reach the desired concentration. The molecules ribavirin, Nile red and 6-azauridine were drug-loaded and
analyzed to ensure encapsulation then released at a pH of 5.4. The nanoparticles had an average diameter
before dissociation of 63.44, 84.73 and 55.25 nm respectively. By utilizing this drug delivery system we
are able to target specific intracellular pH values that are known to occur around landmarks of the cell
and thus can manipulate drug release accordingly. The drug delivery system that is described in this
thesis is designed and analyzed for its future potential to target and successfully suppress Flaviviridae
viruses, such as dengue and Zika virus.
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CHAPTER 1
INTRODUCTION
1.1 The Discovery of Viruses
Ever since the birth of the germ theory of disease by Ignaz Semmelweis and confirmation by
Louis Pasteur, mankind has sought out methods to combat infectious agents that were far too small to be
observed with human eyes.1 At the time, scientists all over the world were noting that some disease
causing agents were too small to be caught by traditional filters and therefore ideas spread that maybe this
was not a bacteria.1 When Louis Pasteur started to prove to the world that microbes could cause diseases,
scientists’ and doctors’ perceived knowledge on the subject started to diminish, therefore sparking the
desire to discover a new world of organisms. Unfortunately, during Pasteur’s day the term “virus” came
from the Latin word for a slimy liquid or poison and often was used interchangeably for any infectious
agent that caused disease. This often led to bacteria being grouped together with what today would be
classified as a virus. Not too long after the acceptance of infectious agents being able to pass through the
smallest filters available did scientists begin to solely refer to these pesky infectious agents as “viruses”. It
was clear that these pathogens could cause problems with very little knowledge on the topic. However, it
was unclear at times how they should deal with them.
With a seemingly endless world to discover ahead it did not take long for the first human virus to
be discovered in 1901 by a team in Cuba. Major Walter Reed, a U.S. Army physician and the team of
Cuban doctors were able to confirm that a virus to which was referred to as “yellow fever virus” was
indeed the cause of the disease, yellow fever.1 The team was also able to identify the host from which
humans were contracting the virus, mosquitoes.1 This was a promising start and the world took notice as
the team from Cuba combated the outbreak of yellow fever that was plaguing the U.S. army.
Since the discovery of viruses in the late 19th century, a lot has been learned about their unique
nature. Viruses are historically characterized by their size along with their biochemical properties such as
protein composition and genetic information.1 Viruses are also noted as the smallest of all self-replicating
organisms.1 The basic components of viruses include a small segment of nucleic acid that is encapsulated
in a simple protein shell. Viruses are reliant on a host in order to carry out tasks such as amplification,
making viruses unique in their lack of metabolism. Because of this there is debate on the topic of viruses
being categorized as “living”. However, it should not be mistaken that the inherent simplicity of viruses
infers a simple group of pathogens.
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Since virology as a discipline is a relatively new field of study and is roughly a century old, early
taxonomy was focused around the diseases caused by viruses. This led to groupings based on concepts
like animal based viruses and human based viruses. Increasing detection of infectious agents and their
identification made it clear a new classification system needed to be created that could adequately
distinguish the various viruses. In 1966, the International Committee on Nomenclature of Viruses (ICNV)
was established and was tasked with the development of a classification and naming system of the
viruses.1 Such a diverse set of viruses made classification based on a single characteristic problematic and
thus the ICNV settled for a polythetic system based on viruses sharing several characteristics. However,
viruses were not required to share all of the characteristics. The classifications ultimately led to the vast
modern day virus taxonomy that is still being adjusted today.1
1.2 Flaviviridae Family of Viruses
Viruses that infect humans were characterized into 21 families. The first human virus discovered
was utilized as the representative for its own family, Flaviviridae. Flaviviridae came from the Latin word
flavus, or yellow, and paid homage to the yellow fever virus first proved in Cuba.1 This virus family was
centered around positive-stranded RNA viruses and members were classified into three superfamilies:
Flavivirus, Pestivirus and Hepacivirus. A fourth
genus, Pegivirus, has recently been proposed to
encompass unclassified viruses that are closest
to Flaviviridae.1 It is predicted with time,
discovery, and greater understanding of viruses
that new classifications along with
reclassifications will occur as the field evolves
with technology.
Flaviviridae are organized around a few
key common features in both viral particle
characteristics and replication life cycle. As
mentioned above, the positive-stranded RNA
viruses that compose the Flaviviridae family fall
into four superfamilies, based on distinctive Figure 1. Life cycle of the Flaviviridae family of viruses.1
similarities. The family as a whole is
typically characterized by their lipid bilayer which consists of two or more envelope (E) glycoprotein
subunits surrounding the nucleocapsid. The nucleocapsid is comprised of the single-stranded, positivesense RNA genome complex that has multiple, basic capsid (C) proteins.
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General replication of the viruses in the Flaviviridae family begins with receptor-mediated
endocytosis. Figure 1 showcases the life cycle of the Flaviviridae family where key steps are dictated by
pH in Table 1.1,2,3 Early fusion of the virion envelope with the cellular membrane occurs, through fusion
due to the low pH of the endosome. After the acid-catalyzed fusion occurs the nucleocapsid starts to
dissociate thus releasing the RNA genome into the cytoplasm. The released RNA finds its way to the
endoplasmic reticulum (ER) where membrane bound RNA replication occurs. It is in the ER where the
positive-stranded RNA template is transformed into RNA for further replication. Some positive strands
can be assembled into virions and are transported to the trans-Golgi to mature before undergoing
intracellular budding and exocytosis to be released from the cell. The RNA genome has three major roles
during the replication life cycle: 1) serve as the messenger RNA (mRNA) for translation of viral proteins,
2) serve as a template in RNA replication, and 3) act as the genetic material packaged within the new
virus particles for further infection of naïve cells.
Table 1. The cellular micro pH values regulating the life cycle of the Flaviviridae family of
viruses.3
Step in Life Cycle
Micro pH
Acid-catalyzed fusion of virus and endosome

5.5

Translation, replication and assembly in the ER

7.2

Maturing of the virions in the Trans-Golgi network

6.7 and 6.0

Intracellular budding and exocytosis

5.7

1.3 The Flavivirus Genus
The Flavivirus genus of the family, Flaviviridae is home to more than 50 species of pathogens, of
which the majority are arthropod-borne human pathogens.1 Viruses in the family are responsible for a
variety of diseases to include fever, encephalitis, and hemorrhagic fevers.1,4-7 In recent years there has
been a global concern over some of the viruses in
this genus to include dengue virus (DENV), West
Nile virus (WNV) and Zika virus (ZIKV).1,4-7 The
infectious particles tend to be roughly spherical in
nature and can be characterized as approximately 50
nm in diameter.1 These viral particles consist of a
shell that is made up of two viral proteins
surrounding a capsid protein which store the viral
RNA of the virus (Figure 2).1,5

Figure 2. Diagram of a typical Flavivirus virus
indicating the outer shell of proteins around the
viral RNA.5
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1.4 Aedes Mosquitoes
The Aedes genus of mosquitoes is
home to two specific mosquito types found in
the United States: Aedes albopictus and Aedes
aegypti, which are commonly the vial vector
for Flaviviridae virus infections. It is the
female mosquitoes that transmit the virus
through biting the host, and a single bite can be
responsible for transmitting more than one
virus. Aedes mosquitoes are traditionally found
in tropical or subtropical locations with
historically noted epidemics of disease
occurring as early as the 17th in countries like
Africa, Americas and parts of Europe however
in recent years with the increase in urban travel
coupled with rising global temperatures the
mosquitoes preferred climate has
broadened.1,4,6,8 Aedes albopictus mosquitoes
tend to flourish in a broader temperature range
and blood feed on both animals and humans
which drops the likelihood of spreading viruses
transmittable to humans.8 The Aedes aegypti

Figure 3. The 2017 CDC estimate of Aedes
mosquitoes ability to live and reproduce in the
United States.8

thrive in warmer climates but prefer to blood feed on humans and therefore are more likely to spread
human transmittable viruses such as dengue virus, West Nile virus, Zika virus, etc.8 The Center for
Disease Control and Prevention (CDC) estimated in 2017, using county-level and historical records that,
Aedes mosquitoes could survive and reproduce in the majority of the southeastern portion of the United
States of America (Figure 3).8 While the CDC only investigated whether or not the mosquitoes could live
and reproduce, it did not indicate if the Aedes mosquitoes had become established in the area. It was the
U.S. army that confirmed the presence of Aedes mosquitoes in Georgia as early as 2016, specifically the
Aedes aegypti.6
1.5 Zika Virus
Zika virus (ZIKV) is an emergent, mosquito-borne virus of the Flaviviridae family that utilizes
the Ades mosquitoes for transmittance.4,5 The virus is spread primarily through the bite of a female Ades
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mosquitoes which is infected with ZIKV however vertical transmission can occur between a pregnant
woman and her fetus.4 The virus was first isolated in a sentinel rhesus monkey in the Zika forest of
Uganda in 1947 and was later detected in the first human in 1952.4,5,6 The majority of cases are either
asymptomatic or mild and include symptoms such as: fevers, rash, conjunctivitis, muscle/joint pain,
malaise and headaches and therefore are underrepresented. However some cases become severe cases and
present with symptoms consistent with Guillain-Barré syndrome or congenital malformations on infants
to include club feet and microcephaly.4,7
Clinical assessment and treatment of Zika infected humans is wildly dependent on the person’s
ability to seek out aid along with the resources of a capable hospital. Cases are often underreported or
dismissed due to lack of resouces.4 Recent outbreaks of ZIKV have been liked to mass travel for events
like major sporting events and warmer temperatures for the host mosquitoes to thrive in.4 Currently, there
are no designated, FDA approved antivirals or vaccines on the market against ZIKV which means
supportive care is the best option against mild to severe symptoms.9 Majority of efforts to slow spread
revolve around education on abstinence from sexual intercourse or barrier protection for 6 months
however a common antiviral, ribavirin has recently indicated some promise as a potential treatment
option in the future.9,10
1.6 Dengue Virus
Another virus that is transmitted via Aedes mosquitoes is dengue (DENV). Like most viruses,
there are neither vaccines nor effective FDA approved therapies against dengue. As a result doctors to
simply manage the symptoms of those infected.11,12 Often characterized by the virus serotypes 1 through 5
(DENV-1 to DENV-5), infection from DENV does not always yield symptoms.13,14 Symptomatic
infections of the virus range from mild as in dengue fever (DF), to severe forms which are referred to as
dengue hemorrhagic fever (DHF) which can progress to dengue shock syndrome (DSS).13 DENV has a
long history in the Americas dating back to 1600’s. Recent outbreaks of dengue in the United States in
Florida, Texas and Hawaii have been noted to be sources of local spreading of this disease marking the
fact that this is no longer a travel-associated disease.15 However, most outbreaks of this virus follow an
endemo-epidemic pattern that yields outbreaks approximately every 3 to 5 years.13 These outbreaks are
often characterized by a temporary, larger than normal increase of cases due to various factors to include
weather and lifestyle patterns. The CDC estimates that 40% of the world’s population live in areas where
dengue is prevalent.15 With a vast portion of the world’s population at risk the need for targeted therapies
is quite clear.
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CHAPTER 2
NANOPARTICLE DESIGN AND APPROACH
The rise in disease carrying mosquitoes in urban areas sheds light on an issues that researchers
have put limited efforts in. The need for targeted treatments for antivirals is clear but the response is
lacking. An answer to this growing problem is to create a nanoparticle system that carries known
antivirals to the locations inside the cell that viruses replicate in. By utilizing the micro pH values found
in cells, a drug delivery system can be modified in order to carry the antivirals directly to where the
viruses are found thus in theory having greater overall success in stopping replication. This approach
requires synthesis of a biocompatible polymer capable of being turned into a tunable nanoparticle system
that is successful in encapsulating and releasing the antiviral on demand.
2.1 Introduction of Biodegradable Coblock Polymers
The use of biodegradable polymers in biomedical applications has recently become a center of
interest due to their wide range of applications.16-19 Unique properties allow scientists to assemble these
medically safe polymers into functioning nano-sized units, increasing the pharmacological applications of
biocompatible polymers.18,19 These biodegradable polymers are broken down, absorbed or eliminated in a
human body shortly after their purpose has been fulfilled, making them desirable in biomedical
applications.20 Often biodegradable co-block polymers are utilized in fabrication of biomaterials, which
refers to natural and/or synthetic substances that are engineered to interact specifically with biological
systems in order to direct medical treatment.20 This is due to the fact that they do not require removal or
special handling in order to meet long-term safety requirements. In theory, biodegradable polymers
degrade at a rate that is approximately equal to the healing or regeneration processes of the body in which
they are designed to aid. 20 The degradation of the polymer products also are nontoxic, metabolized, and
excreted easily, therefore making biodegradable co-block polymers the sensible choice for countless
environmentally friendly and biomedical applications.16-20
Biodegradable co-block polymers in drug formulation is a multifaceted endeavor. Scientists
merge biocompatible monomers that are specifically chosen for advantageous properties, such as drug
solubility and dissociation.16,17 Specifically arranged monomers or “blocks” combine into copolymers and
allow scientists to explore the promising biomedical applications, to include drug delivery systems, since
amphiphilic block copolymers have been noted to self-assemble to form polymeric micelles under certain
concentrations.16 By selecting polymers with properties such as pH-responsive dissociation, thermal self-
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assembly or even hydrophobicity properties, a new era of tunable systems can emerge to increase
selectivity and decrease toxicity.16-20
2.2 Triblock mPEG-PCL-mPEG Polymer
The triblock, mPEG-PCL-mPEG is a solid candidate for biocompatible materials due to its pHresponsive dissociation, thermal self-assembly and hydrophobicity properties.16,17,21 The polymer chain,
mPEG-PCL-mPEG, gets its name
from the three segments that are
joined to form a single triblock strand:
polyethylene glycol, poly(ecaprolactone) and another
polyethylene glycol. Polymer segment
patterns are often shorthanded to
alphabetic patterns that assign letters

Figure 4. General scheme of an ABA triblock formation.

to each respective monomer unit. For
the mPEG-PCL-mPEG triblock polymer the letters assigned would be, “ABA” since the end units are the
same monomer. Here the “A” units refer

O
H3C

O

n

O

H

+

O
O

H3C

O
n

O

O

H

m

Figure 5. AB diblock formation via ring-opening
polymerization of e-caprolactone.

to the polyethylene glycol or PEG which
caps the “B” unit of poly(e-caprolactone).
The A monomer is coupled to the B
monomer to form a diblock which is then

capped with another A monomer in order to form the complete ABA triblock polymer (Figure 4).
Polymerization of the ABA triblock occurs through two steps, open ring polymerization of the ecaprolactone utaliziling polyetheylene glycol as the macro-initiator and stannous octoate as the catalast
then combining the diblock through modification of the hydroxyl group of a polyetheylene glycol to a
carboxylic acid in order to be conneceted to the previously formed diblock (Figure 5 & 6).16,17,21
The synthesized triblock, mPEG-PCL-mPEG, is useful as a biomaterial due to its unique ability to
undergo thermal induced self assembly without the need for harsh solvents along with its disociation
point of a pH of 5.4, the pH of the late endosome.16,17,20 By strategically lining up under special thermal
requirements, the solvent can remain
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O
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O

Figure 6. The reaction for PEG monomer formation
to be coupled with the AB diblock.

biocompatable and with a disociation point
revolving around a pH of 5.4 the polymer can
target the acid-catalyzed fusion of virus and
endosome where viral RNA is released and
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initiated for replication in the ER.1-3,16,17,20 It is these advantageous biodegradable and nontoxic properties
that make the ABA triblock polymer enticing as a possible drug delivery system.17
2.3 mPEG-PCL-mPEG Micelles
Nanoparticles are currently pursued to enhance or replace older medical therapies due to their
interesting and tunable properties.18 From image enhancing to antimicrobial effects to drug delivery
systems, nanoparticle uses seem bound
only by one’s imagination.18 Scientists
find nanoparticles’ unique properties of
selectivity, size, shape and
biocompatibility allow for increased
specificity, making them highly sought
after in biomedical applications.18
Biodegradable polymeric nanoparticles
composed of segmented biocompatible
polymers spark the interest of scientists

Figure 7. ABA triblock polymer based, drug-loaded
micelles.

due to their ability to form micelles/vesicles that can be optimized for their release under specific
parameters.16 Polymeric micelles can be divided into two sections, the outer shell and their inner core
(Figure 7). Scientists have determined that drug loaded micelles with an outer hydrophilic shell have
bonus effects in the body, including increased circulation time of drugs, in vitro stabilization, and
prevention of recognition by macrophages post-intravenous injection.22 Polymer-based nanoparticles
made from mPEG-PCL-mPEG create a hydrophilic bubble which allows for drug-loading of numerous
polar molecules and when coupled with the known pH responsiveness of the system can be utilized in
targeting key micro pH values important in viral reproduction (Table 1). By creating a bubble for the
drugs to be loaded into common hurdles for drug development, water solubility for intravenous
administration can be easily met without the need to alter the drug itself.23

2.4 Thermal Induced Self-assembly of Polymeric Micelles
The amphiphilic block copolymers introduced in section 2.3 assemble under unique conditions.
The copolymers can self-assemble into polymeric micelles in an aqueous solution, thus creating the
perfect environment for hydrophobic drugs.16,23 Depending on the needs for the drug the inner core of the
micelle can be designed to match the best environment for the drug, either hydrophilic or hydrophobic.
While previous labs have used environments suited for redox reactions or solvent swaps in order to
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assemble and drug load their micelles, an issue arises in the purity, and can lead to increased cytotoxicity
once the sample is finalized.16,19,23 The possibility of harsh organic solvents being left behind in solution
leads to ethical questions of purity. A new method to form the micelles which aims to avoid these ethical
topics is “thermal induced self-assembly”. Self-assembly of the polymeric micelles in this fashion
revolves around the idea that the polymers display thermosensitivity and, thus, when exposed to a sharp
transition in heat they tend to aggregate in an orderly manner thus forming spherical shells that can be
utilized as a carrier (Figure 7).23 Since the only requirement for the formation of the micelles is the sharp
transition of heat, the need for harsh solvents is eliminated, and the formation can be placed in a
biologically friendly solvent such as ultra-pure water.
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CHAPTER 3
DRUG-LOADING OF MICELLES
3.1 Introduction to Drug-loading of Polymeric Micelles
The polymeric micelles discussed above are designed with one overarching goal in mind: to
deliver the drug of choice into a specific region and then release it in a manner that is safe, effective, and
efficient. The concept of a drug delivery system is not new, with the past 25 years seeing the bulk of
research growth in biodegradable/biocompatible materials such as polymers.20,24,25 With the ability to
yield high drug-loading capacity in relationship to relative size, nanomaterials composed of polymers can
offer more than traditional methods of drug dosing.24 Higher specificity brought on by strict pH-specific
dissociation results in higher accumulations of drugs at targeted locations. Since the reported average
diameters of polymeric micelles ranging from 30-50 nm, close to the size of most viruses, the micelles are
easily uptaken by the cell.23,24 Another benefit to the drug delivery system is that the polymer-based shell
creates a protective cover over the drugs which results in the in vitro stabilization of the drug due to
protection of this drug from various destructive agents found in the body.25 Simply put, the shell is
thought to disguise the drug from the body’s protective mechanisms. With less drug required in order to
effectively dose a patient, cytotoxicity concerns also decrease. There is a low risk of chronic
accumulation in the body, especially when the polymer components used are considered biocompatible.25
Drug-loading of polymeric micelles can be achieved through 3 common methods: direct
dissolution, solvent evaporation, and dialysis.25 Depending on the solubility of the polymeric micelles and
the drug, the most common methods are direct dissolution and solvent evaporation.16,19,23,25-27 In these
methods, the polymer micelles are suspended in solvent (water for direct dissolution or an organic solvent
for solvent evaporation) and occasionally subjected to temperature increases to enhance drug loading.23-26
When the polymer blocks are long, i.e. more than 4 or 5 blocks and/or hydrophobic, the micelles do not
drug-load easily and therefore require a different method, dialysis. In this method a solvent exchange
occurs through the dialysis tubing which facilitates the exchange of water and drug in order to drug-load
the micelle.25 This method is highly effective for larger micelle complexes. However, this method tends
to be a lengthy process since dialysis requires solvent adjustments in a timely manner.
The method utilized in drug-loading of the triblock polymeric micelles, such as mPEG-PCLmPEG, is based on direct dissolution and is referred to as “thermal induced self-assembly and loading”
(Figure 6).23 This method is ideal for a few reasons, including lower risk of toxicity and speed of drug
loading. Based on the concept that when micelles are suspended in a solvent in which the drug of choice
is also suspended, the drug will “load” into the micelles to increase stability when subjected to a change
in temperature.23,25-27 The use of heat coupled with sonication aids in drug loading to enhance output of
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correctly formed micelles that encapsulate the drugs. 23,25-27 Since heat can drive the formation and drug
loading of the micelles, the mPEG caps of the triblock employ an important role in this process. During
the thermal induced self-assembly and drug-loading, the ABA block polymer utilizes PEGylated ends to
control the particle size and prevent aggregation over long periods of time.28 It has also been reported that
the PEGylated lipid mimic acts as a temporary immune shield from the body’s defense system for the
drugs.28 By utilizing only heat and sonication for the formation and drug-loading process, there is no fear
of in vitro toxicity due to remnant organic solvents.

Figure 8. General scheme of thermal induced self-assembly and drug-loading of ABA triblock-based
micelles. Drug-loading of micelles is achieved when the polymer is heated to form the micelles. Then the
drug of choice is added to the suspension just prior to sonication of the solution.

3.2 Topological Polar Surface Area
Determination of the ideal amount of any drug to load into the micelles requires a unique
approach in order to decrease wasted drug. Since drug carriers of various sorts have become wildly
popular in recent years, the methods surrounding determining how much to drug load, along with how to
drug load, has become almost overwhelming. 16,19,23,25-27 Researchers who conjugate the drug to the
polymer itself have a vastly different approach than the researchers who free load the drugs onto the
micelles and therefore the outcomes often vary.23,25,26,29 Another factor to consider is that antiviral drug
properties/bioavailability is often not as easily accessible or researched as other drug candidates, such as
cancer treatments. Previous uses for drug carriers on the market or in development are dominated by
anticancer drugs.23,25,26 Lipid mimics or lipid nanoparticles have not been utilized as frequently with other
drug candidates until recent years.29 This setback has recently been overcome with the development and
widespread use of Moderna’s and Pfizer’s vaccines that target prevention of the disease COVID-19,
which stems from infection of SARS-CoV-2.29 The vaccine which is a PEGylated lipid that houses
mRNA of the virus is credited as the first widespread successful use of a lipid micelle.29 Since the vaccine
is a recent achievement and therefore not an applicable tool on which to base any drug-loading, scientists
had to adapt data from other sources in order to relate drug-loading of less common options such as
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antivirals. It is no secret that cancer is the top funded research on any disease in the world.30,31 With just
the United States budget in 2018 sitting at $5.94 billion it is easy to say that anticancer drugs are some of
the most researched options for drug-loading into the micelles.31 Established concentrations of common
anticancer drugs (e.g. doxorubicin) to load into specific coblock polymer micelles can be related to lesser
studied drug candidates, like antivirals, in order to determine an ideal drug loading amount.23,25,26
To relate two different drugs for drug loading, a method called topological polar surface area can
be used. Topological polar surface area or TPSA is a common descriptor that is defined as the sum of the
surface of all the polar atoms in a given molecule.32,33
TPSA is a modern method compared to its older

Fragment Based
Approach (TPSA)

Traditional
Approach (PSA)

Identify Polar
Fragments

Generate 3D
Structure

Determine PSA
Contributions
of Fragments

Calculate
Surface

Calculate Sum

Identify Polar
Atoms

counterpart, polar surface area (PSA), and TPSA, which
specifically utilizes software that itemizes polar fragments
of the drug compound then determines the individual PSA
contributions in order to determine the molecule’s
combined TPSA.32,33 TPSA allows for a quicker and
simple method of calculating a molecule’s polar surface
area when compared to PSA (Figure 9), due to the lack of
3D structure which is traditionally required for software
calculations of PSA.33 The tabulated total polar surface
area, calculated via TPSA, allows for the direct
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comparison of drug loading capabilities of the wellstudied anticancer drug candidates to the lesser studied drug
candidates such as antivirals.

Figure 9. Comparison of determination
of a molecule’s TPSA to PSA.

3.3 Introduction of the Antiviral, Ribavirin
The guanosine analog, ribavirin has become a long standing frontline antiviral due to its’ broad
spectrum of antiviral activity (Figure 10).10,34-36 The
N

mechanism of action for ribavirin is centered
around its ability to function as a mutagen, thus
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increasing error catastrophe in replication.34 Since
ribavirin has the ability to become incorporated into
the viral RNA, it directly inhibits viral RNA
synthesis and therefore induces viral genome
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Figure 10. Structure of the antiviral, ribavirin;
TPSA: 143.73 Å²

mutations which ultimately lead to inhibition of
normal viral replication.34,35 As a broad spectrum antiviral, ribavirin has been proven successful in lab
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settings of suppression for numerous viruses such as hepatitis C, respiratory syncytial virus, Lassa fever
virus, dengue, and Zika viruses. However, ribavirin is currently only approved by the U.S. Food and Drug
Administration for the treatment of hepatitis C infections.10,34,35,37
3.4 Introduction of the Fluorescent Tracking Dye, Nile Red
Nile red, or Nile blue A oxazone, is a
photostable polarity-sensitive fluorescent probe that
fluoresces intensely at 552 nm and can be utilized as

a

fluorescent stain for determination of intracellular
uptake (Figure 11).10,38-41 This lipophilic fluorescent
probe is ideal for determining uptake and
intracellular distribution due to its excitation at
552nm and its ability to be drug-loaded into
nanoparticles in a similar manner to the typical drug
candidates.38-41 Commonly used as a histological dye,

Figure 11. Structure of the fluorescent
probe, Nile red; TPSA: 46.34 Å²

Nile red is easily adapted to function as a fluorescent probe in nanomaterials allowing scientists to study
uptake and distribution with in vitro studies.39-41
3.5 Introduction of the Antiviral, 6-Azauridine
The analogue of uridine, 6-Azauridine, is another common broad
spectrum antiviral that is commonly tested alongside the previously
mentioned antiviral, ribavirin (Figure 12).10,42-44 It has been reported that
6-Azauridine has positive antiviral activities when tested in vitro against
a minimum of 11 different pathogenetic Flavivirus viruses to include
dengue and Zika. However, it should be noted that at this time, 6Azauridine has not been FDA approved of the treatment for any virus due
to concerns about toxicity in significant quantites.42-44 This drug’s
antiviral activity is attributed to increasing the levels of uridine kinase,
which converts uridine to uridine monophosphate, a nucleotide used in
viral RNA synthesis.43,44 While 6-azauridine can possess toxic effects in
large amounts, in vitro studies have shown some antiviral properties with
concentrations below those leading cytotoxcicity.43,44

Figure 12. Structure of the
antiviral, 6-Azauridine;
TPSA: 132 Å²
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CHAPTER 4
MATERIALS AND METHODS
4.1 Synthesis of Triblock polymer, mPEG-PCL-mPEG
Synthesis of mPEG-PCL-mPEG triblock polymers occurs through coupling AB diblock
copolymers with a capped A monomer. The chemicals for the AB diblock, poly(ethylene glycol) methyl
ether or mPEG (CAS# 9004-74-4, Mn 5,000), were purchased from Aldrich, epsilon-Caprolactone or ecaprolactone (CAS#502-44-3) and Tin(II) 2-ethylhexanoate or stannous octate (CAS#301-10-0) were
purchased from Alfa Aesar, methylene chloride or dichloromethane (CAS#75-09-2) were purchased from
Fisher Chemical, diethyl ether (CAS#60-29-7) were purchased from VWR, and hexane (CAS#110-54-3)
was also purchased from Fisher Chemical. The chemicals to synthesize the capped A monomer, succinic
anhydride (CAS# 108-30-5) was purchased from ACROS Organic, 1,4-dioxane (CAS#123-91-1) came
from Fisher Chemical and 4-(Dimethylamino) pyridine (CAS# 1122-58-3) was purchased from Alfa
Aesar. The chemicals to couple the AB diblock to the capped A monomer, 4-(Dimethylamino)pyridine
(CAS# 1122-58-3), was purchased from Alfa Aesar, N,N’-Dicyclohexylcarbodiimide (CAS#538-75-0)
was purchased from ACROS Organic, diethyl ether (CAS#60-29-7) was purchased from VWR and
hexane (CAS#110-54-3) was purchased from Fisher Chemical.
To synthesize the mPEG-PCL-OH AB diblock, a ring-opening polymerization of e-caprolactone
utilizing mPEG as a macro-initiator and stannous octate as catalyst occurs. Under a protective nitrogen
atmosphere, 4mL of e-caprolactone, 2 g of mPEG and 100µL of stannous octate reflux at 130°C for 4
hours. Once refluxed the solution is dissolved in dicholoromethane, then precipitated in 9:1 v/v
concentration of chilled diethyl ether : hexane. The AB diblock polymer is then recovered and stored until
the A monomer is completed.
To synthesize the capped A monomer, 0.2769 g of mPEG and 0.2001 g of succinic anhydride is
allowed to react at room temperature in the presence of 3 mL of 1,4-dioxane and 0.0012 g of 4(Dimethylamino)pyridine for 24 hours. The reaction (Figure 3) yields the capped monomer, mPEGCOOH, which is then ready to be coupled with the AB diblock, mPEG-PCL-OH.
The mPEG-PCL-OH based AB diblock is then coupled with the A monomer, mPEG-COOH, via
the addition of 0.00433 g of 4-(Dimethylamino)pyridine and 0.02933 g of N,N’Dicyclohexylcarbodiimide. This mixture is then allowed to react under the protection of nitrogen for 24
hours, creating an ABA triblock polymer of mPEG-PCL-mPEG. The polymer is suspended in 1:1 v/v
concentration of chilled diethyl ether : hexane and dialyzed (Fisherbrand regenerated cellulose dialysis
tubing, nominal MWCO 12,000-14,000) against ultrapure DI water (18.2 MW.cm at 25°C) for 12 hours,
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changing the water every 4 hours. The final solution is lyophilized (LABCONCO FreeZone 4.5 Plus) and
stored at -20°C until characterization on Fourier-transform infrared spectroscopy (Thermo Scientific
Nicolet iS10) or until further use.
4.2 Synthesis of mPEG-PEC-mPEG Micelles
The ABA triblock polymer, consisting of mPEG-PCL-mPEG, can then be utilized to form blank
micelles with an empty core. To synthesize blank micelles, the previously mentioned lyophilized mPEGPCL-mPEG triblock polymer is dissolved in ultrapure DI water (18.2 MW.cm at 25°C) at a ratio of 20 mg
of polymer in 1 mL of water and placed in a water bath (Thermo Scientific Precision CIR 19) at 50°C for
15 minutes, initiating thermal induced self-assembly of micelles. Once self-assembly is complete, the
solution is filtered through a 0.2 µm syringe filter (Corning sterile syringe filter part no. 431215) and the
filtrate containing blank micelles is characterized using UV-Visual spectroscopy (Shimadzu UV-2600
UV-VIS Spectrophotometer) and dynamic light scattering (Malvern Nano series NANO-ZS ZetaSizer).
4.3 Ribavirin Drug-loaded mPEG-PCL-mPEG Micelles
The amount of ribavirin needed to fully drug-load the sample was based on the molecules
topological polar surface area or TPSA. Since TPSA is a common descriptor that is defined as the sum of
the surface of all the polar atoms in a given molecule, ribavirin’s TPSA could be calculated and compared
to the drug loading capacity of a known cancer drug, doxorubicin.32,33,36 Ribavirin’s TPSA was calculated
via the software, Molinspiration Cheminformatics and was determined to be 143.73 Å².36 Doxorubicin’s
TPSA was also calculated using the same software and was determined to be 206 Å².36 For doxorubicin’s
drug loading capacity of 3 mg per 20 mg of triblock polymer, ribavirin is drug loaded at a rate of 4.5 mg
per 20 mg of triblock polymer.
In order to drug-load the blank mPEG-PCL-mPEG micelles with ribavirin, 98% ribavirin was
purchased from ACROS Organic (CAS#36791-04-5), and was combined with the blank micelle
suspension at a ratio of 4.5mg of ribavirin per 1mL suspension of the previously suspended blanks in
ultra-pure DI water (18.2 MW.cm at 25°C). The solution is sonicated in a Bransonic ultrasonic water bath
(CPXH series) at 37°C for 30 minutes on high. Once finished the solution is then passed through a 0.2 µm
syringe filter (Corning sterile syringe filter part no. 431215) to remove any ribavirin that aggregated
instead of loading into the micelles. Final characterization of the micelles using UV-Vis spectroscopy
(Shimadzu UV-2600 UV-VIS Spectrophotometer) and dynamic light scattering (Malvern Nano series
NANO-ZS ZetaSizer) ensures ribavirin was correctly loaded into to nanoparticles.
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4.4 Kinetics Study of Ribavirin-loaded mPEG-PCL-mPEG Micelles
In order to create a ribavirin standard, 10 samples with concentrations from 0.025 g/3.5 mL to
0.25 g/3.5 mL were created from a stock of 1 g/3.5 mL. The 98% ribavirin was purchased from ACROS
Organic (CAS#36791-04-5) and dissolved in ultrapure DI water (18.2 MW.cm at 25°C). The stock and
aliquots were suspended further in ultrapure DI water to create the various samples. The 10 samples
comprising the ribavirin standards were then analyzed using UV-Vis spectroscopy (Shimadzu UV-2600
UV-VIS Spectrophotometer) and a standard was determined at 270nm.
The release of ribavirin from the triblock micelles occurred through dissociation of the micelles
started by the change in pH. Ribavirin-loaded micelles were synthesized as mentioned in Section 4.3 and
the pH was corrected via dropwise addition of phosphate buffer saline or PBS bought from SigmaAldrich (Lot # D8537) until the pH was measured to be 5.49 using a Fisherbrand accumet benchtop pH
meter. The sample was then analyzed using UV-Vis spectroscopy (Shimadzu UV-2600 UV-VIS
Spectrophotometer) and dynamic light scattering (Malvern Nano series NANO-ZS ZetaSizer) for the
remainder of the experiment.
4.5 Nile Red Drug-loaded mPEG-PCL-mPEG Micelles
The amount of Nile red needed to fully drug-load the sample was based on the molecule’s
topological polar surface area or TPSA. Nile red’s TPSA could also be calculated and compared to the
drug loading capacity of a known cancer drug, doxorubicin.16 Nile red’s TPSA was calculated via the
software Molinspiration Cheminformatics, and was determined to be 46.34 Å².36 Doxorubicin’s TPSA
was previously calculated using the same software and was determined to be 206 Å².36 Comparison of
doxorubicin’s drug loading capacity to Nile red, doxorubicin can load 3mg per 20mg of triblock polymer
while Nile red is able to drug load 0.5 mg per 20 mg of triblock polymer.
In order to drug-load the blank mPEG-PCL-mPEG micelles with the fluorescent tracking dye,
Nile red, was purchased from Tokyo Chemical Industry (CAS#7385-67-3), and was combined with the
blank micelle suspension at a ratio of 0.5 mg of Nile red per 1 mL suspension of the previously suspended
blanks. The solution was sonicated in a Bransonic ultrasonic bath (CPXH series) at 37°C for 30 minutes
on high. Once finished the solution was then passed through a 0.2 µm syringe filter (Corning sterile
syringe filter part no. 431215) to remove any Nile red that aggregated instead of loading into the micelles.
Final characterization of the Nile red-loaded micelles was performed using UV-Visual spectroscopy
(Shimadzu UV-2600 UV-VIS Spectrophotometer) and dynamic light scattering (Malvern Nano series
NANO-ZS ZetaSizer) ensures that Nile red was correctly loaded into to nanoparticles.
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4.6 6-Azauridine Drug-loaded mPEG-PCL-mPEG Micelles
The amount of 6-azauridine needed to fully drug-load mPEG-PCL-mPEG micelles was based on
the molecule’s topological polar surface area or TPSA. The 6-azauridine’s TPSA could also be calculated
and compared to the drug loading capacity of a known cancer drug, doxorubicin.16 The 6-azauridine’s
TPSA was calculated via the software Molinspiration Cheminformatics and was determined to be 132
Å².36 Doxorubicin’s TPSA was previously calculated using the same software and was determined to be
206 Å².36 For doxorubicin’s drug loading capacity of 3 mg per 20 mg of triblock polymer, 6-azauridine’s
is able to drug load 4.9 mg per 20 mg of triblock polymer.
In order to drug-load the blank mPEG-PCL-mPEG micelles with 6-azauridine, 6-azauridine was
purchased from Biosynth Carbosynth (CAS#54-25-1), and is combined with the blank micelle suspension
at a ratio of 4.9mg of ribavirin per 1mL suspension of the previously suspended blanks. The solution is
sonicated in a Bransonic ultrasonic bath (CPXH series) at 37°C for 30 minutes on high. Once finished the
solution is then passed through a 0.2 µm syringe filter (Corning sterile syringe filter part no. 431215) to
remove any leftover 6-azauridine that aggregated instead of loading into the micelles. Final
characterization of the micelles using UV-Visual spectroscopy (Shimadzu UV-2600 UV-VIS
Spectrophotometer) and dynamic light scattering (Malvern Nano series NANO-ZS ZetaSizer) ensures that
6-azauridine was correctly loaded into to nanoparticles.
4.7 Drug Release Study of 6-Azauridine Drug-loaded mPEG-PCL-mPEG Micelles
The release of 6-azauridine from the triblock micelles occurred through dissociation of the
micelles and was initiated through decreasing the pH in the cuvette. The 6-azauridine-loaded micelles
were synthesized as described in Section 4.6 and the pH was corrected via dropwise addition of phosphate
buffer saline or PBS bought from Sigma-Aldrich (Lot # D8537) until the pH was measured to be 5.74
using a Fisherbrand accumet benchtop pH meter. The sample was then analyzed using UV-Vis
spectroscopy (Shimadzu UV-2600 UV-VIS Spectrophotometer) and dynamic light scattering (Malvern
Nano series NANO-ZS ZetaSizer) in order to ensure dissociation of the micelles.
4.8 6-Azauridine Standard
In order to create the 6-azauridine standard, 7 samples with concentrations ranging from 0.01
g/mL to 0.1 g/mL were created from a 6-azauridine stock solution of 0.1 g/mL. The 6-azauridine was
purchased from Biosynth Carbosynth (CAS#54-25-1), and dissolved in ultrapure DI water (18.2 MW.cm
at 25°C) for the stock, and aliquots were suspended further in ultrapure DI water to create the various
samples. The 7 samples were then analyzed by UV-Visual spectroscopy (Shimadzu UV-2600 UV-VIS
Spectrophotometer) and a standard spectral emission was determined to be 317 nm.
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CHAPTER 5
RESULTS
5.1 Characterization of the Triblock, mPEG-PCL-mPEG
The triblock polymer, mPEG-PCL-mPEG, was synthesized following a previously reported
16

method. To ensure correct formation of the triblock, Fourier-transform infrared spectroscopy, or FTIR,
was performed on the A monomer (mPEG) along with the full ABA triblock (Figure 13). FTIR peaks
were compared to literature values in order to confirm the addition of the capped end onto the middle,
diblock segment. The addition of the peak around 1700 cm-1 in the triblock polymer indicates the
presence of the esters in the PCL segment, while the extra peak around 2900 cm-1 on the traditional broad
OH peak is attributed to CH stretching found in the mPEG segments of both polymers and the addition of
the small peak in the fingerprint region at 1100 cm-1 is the ether stretching.16

Figure 13. FTIR analysis of the capped A monomer, mPEG-OH, alongside the complete triblock polymer,
mPEG-PCL-mPEG. The complete polymer is shown stacked on top of the capped monomer.
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5.2 Characterization of Ribavirin-loaded mPEG-PCL-mPEG Micelles
Drug-loaded triblock micelles consisting of the copolymer, mPEG-PCL-mPEG, and the drug,
ribavirin, were synthesized using thermal induced self-assembly and drug-loading. Polymer based
micelles without any drugs loaded into them, called “blanks,” were synthesized initially and checked to
ensure micelle formation occurred before moving on to drug loading. Figure 14 shows UV-visual
spectroscopy spectra of the ribavirin-loaded micelles compared to the blank triblock micelles. Loaded
mPEG-PCL-mPEG micelles have a broad peak that occurs at approximately 270 nm while the blanks are
slightly red shifted and have a broad peak around 300 nm.

Figure 14. UV-visual spectroscopy comparing ribavirin loaded along with blank mPEG-PCL-mPEG
micelles suspended in ultra-pure DI water.

27
The drug-loaded micelles
were further characterized in order to
ensure overall quality. In order to
predict major repulsive or attractive
forces that could become an issue
once the micelles are tested in vitro,
micellar surface charge was measured
via zeta potential and the average
diameter of each micelle particle in
suspension was calculated through
dynamic light scattering. The zeta
potential of ribavirin-loaded mPEGPCL-mPEG micelles is -3.74 ± 0.675
mV (Figure 15) while the average
diameter of the micelles is 63.44 ±
8.615 nm (Figure 16). It is significant
to ensure the surface charge of the

Figure 15. Zeta potential of the mPEGPCL-mPEG micelles suspended in ultrapure DI water.

micelles is within ±30 mV in order to
assume that the micelles will not experience any attractive or repulsive forces when tested in vitro.46

Figure 16. Average diameter of the drug-loaded mPEG-PCL-mPEG micelles suspended in
ultra-pure DI water determined by dynamic light scattering.
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5.3 Kinetics Study of Ribavirin-loaded mPEG-PCL-mPEG Micelles
To test pH-responsive drug release, an initial kinetics study was performed on a standard of the
drug ribavirin. A standard of 10 samples with varying amounts of ribavirin dissolved in 3.5mL of DI
water was created by taking the UV-visual spectroscopy of the 10 samples and then comparing their
absorbances at 270 nm to assess their concentration of drug in mg/mL (Figure 17 & 18). The samples
showed enough separation at 270nm that a linear equation to determine concentration based on the
absorbance could be reasonably assumed. The inlet on figure 17 at the top right is the portion of the
spectrum (250nm-300nm) where the separation of each spectra occurs. The ribavirin-loaded samples
are relatively unremarkable before and after that range with the greatest separation occurring at 270nm.
The separation found at 270nm was plotted using the concentration and absorbance variances in order to
produce the standard shown in figure 18. The linear separation found at 270nm yielded the equation that
would be used in future determination of drug release.

Figure 17. UV-Visual spectroscopy of varying concentrations from 0.025g/3.5mL to 0.25g/3.5mL of
ribavirin in DI water. The inlet at the top right shows a closer look at the separation of the samples.
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Figure 18. Standard created of ribavirin utilizing data from Figure 17 at
270nm.
Second, a kinetics study involving the release of ribavirin from the triblock, mPEG-PCL-mPEG,
was initiated with 1.5mL of ribavirin-loaded mPEG-PCL-mPEG micelles that were characterized prior to

Figure 19. UV-visual spectra of kinetics study to determine release of ribavirin.
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and following pH adjustment to pH of 5.49, thus
signifying the beginning of dissociation. These

Table 2. Elapsed time of the sample for the kinetics
study.

samples, were assessed by UV-visual spectroscopy
in the wavelength range of 800nm to 200nm,
coupled with dynamic light scattering to monitor
the release of the drug (Figures 19 & 20, Table 2).
The first UV-visual spectra obtained after
dissociation occurred at the 6 minute mark and was
the most rapid the sample could be pH corrected,
measured, and assessed in the instrument. The
sample showed a complete release of the ribavirin
at that point (i.e. by 6 minutes). However, the
sample was analyzed for 11 more data points to
track any changes that might occur. The initial
average diameter of the drug-loaded micelles
determined from run 0 was 58.94 ± 6.051 nm while
runs 1-12 showed an increase in instability
consistent
with the concept of dissociation. The difference in
absorbance from runs 1-12 was minimal, while the average diameter varied. Taken together these results
show that successful dissociation of mPEG-PCL-mPEG occurred at pH 5.49, leading to complete release
of ribavirin from these micelles. This release of drug is significant because the pH of the late endosome is
approximately pH 5.4 to 5.5, the intended target for pH-responsive release.

Figure 20. Average diameter of micelles in kinetics study as dissociation
occurs after adjustment of pH values past a pH of 5.4.
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5.4 Characterization of Nile Red-loaded mPEG-PCL-mPEG Micelles
Nile red-loaded micelles were synthesized and characterized similarly to their ribavirin
counterparts. The sample was characterized using UV-vis spectroscopy along with dynamic light
scattering in order to ensure that the particles were fully formed and similar to the ribavirin loaded
micelles (Figure 21 & 22). The average diameter of the Nile red-loaded micelles was determined to be
84.73 ± 54.16 nm using dynamic light scattering, thus keeping the micelle well within the limits of easily
being uptaken by cells.

Figure 21. UV-visual spectroscopy of the Nile red loaded and blank, triblock micelles. Both
samples were suspended in ultra-pure DI water and analyzed under stable conditions.

Figure 22. Average diameter of Nile-red loaded mPEG-PCL-mPEG micelles
suspended in ultra-pure DI water.
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5.5 Characterization of 6-Azauridine-loaded mPEG-PCL-mPEG Micelles
Triblock, mPEG-PCL-mPEG micelles were synthesized once again. Instead of loading with
ribavirin, however they were loaded with the potential anti-Zika virus drug, 6-azauridine. The sample was
characterized using UV-visual spectroscopy coupled with dynamic light scattering in order to ensure that
the micelles were fully formed and similar to the original ribavirin-loaded micelles (Figures 23 & 24).
The peak absorbance for the 6-azauridine-loaded micelles was slightly red-shifted and was closer to 300
nm in emission while the average diameter of the 6-azauridine-loaded triblock micelles was determined to
be 55.25 ± 23.90 nm, as shown by dynamic light scattering.

Figure 23. UV-visual spectrum of 6-azauridine-loaded mPEG-PCL-mPEG micelles
suspended in ultra-pure DI water.

Figure 24. Average diameter of 6-azauridine-loaded mPEG-PCL-mPEG
micelles, suspended in ultra-pure DI water, determined by dynamic light
scattering.
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5.6 Drug Release Study of 6-Azauridine-loaded mPEG-PCL-mPEG Micelles
The 6-azauridine-loaded micelles were tested in a similar method to the ribavirin-loaded mPEGPCL-mPEG micelles to ensure drug release via pH correction. Once corrected to a pH over 5.4 the
micelles begin to dissociate and are monitored using UV-visual spectroscopy coupled with dynamic light
scattering to ensure dissociation (Figure 25 & 26). The absorbance decreased, which is consistent with
drug release, and the average diameter of the 6-azauridine-loaded mPEG-PCL-mPEG micelles after
dissociation increased and was determined to be 76.88 ± 17.16 nm using dynamic light scattering.

Figure 25. UV-visual spectra of 6-azauridine-loaded and dissociated mPEG-PCL-mPEG micelles
suspended in ultra-pure DI water.

Figure 26. Average diameter of 6-azauridine-loaded mPEG-PCL-mPEG micelles
suspended in ultra-pure DI water, after dissociation via a change in pH, determined by
dynamic light scattering.
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A standard of 6-azauridine was created using a similar method to ribavirin’s standard. Varying
concentrations of the drug, 6-azauridine was dissolved in DI water to achieve specific concentrations of 6azauridine in g/mL. The samples had UV-Visual spectra collected to determine the best wavelength for a
standard and the determined wavelength used to gather absorbances in order to create a standard at 317
nm to aid in determining drug release (Figures 27 & 28).

Figure 27. UV-Visual spectroscopy of varying concentrations of 6-azauridine ranging
from 0.1g/mL to 0.075 g/mL suspended in ultra-pure DI water.

Figure 28. Standard of 6-azauridine at 317nm.
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CHAPTER 6
DISCUSSION
Micelles made from co-block biodegradable polymers have a specific goal in mind, to deliver the
drug of choice into a specific region then release it in a manner that is safe, effective, and efficient. This
might sound similar to other nanoparticle drug delivery options, such as liposomes, however micelles
preform their job differently. Micelles consist of a single layer of a lipid or lipid mimic while liposomes
consist of a bilayer or two layers of the same lipid/lipid mimic.45 The single layer in micelles is important
to their ability to undergo pH dissociation, thus releasing their payload under optimal circumstances. By
creating a system that is pH dependent the micro pH values found inside cells can be targeted, thus
decreasing the amount of required drug. The concept of a drug carrier based on pH responsive lipid
mimics is a relatively novel field with limited research revolving around anticancer drugs and targeting
micro pH values of cancer cells.16,23,32,33,36,44 With no previous work published on antivirals being drugloaded into micelles that are lipid or lipid mimics the research presented is the purest form of a novel
concept.
To synthesize the pH dependent micelles, first the biocompatible polymer capable of being
formed into a drug carrier had to be made. The ABA, triblock polymer, mPEG-PCL-mPEG was
synthesized following a previously reported method.16 While the previous lab have determined the pH
dissociation and biocompatibility of the polymer, they were focused on using it as an anticancer drug
carrier and thus had a different use for their system. In order to make the complete polymer, the A
monomer consisting of mPEG or polyetheylene glycol was coupled to the B monomer, poly(ecaprolactone), to form the AB diblock. The AB diblock was then capped with another of the same A
monomer through polymerization in order to form the complete ABA triblock polymer. Once synthizised
the polymer underwent characterization to ensure correct formation of the triblock. Fourier-transform
infrared spectroscopy was run and analyzed on the A monomer along with the full ABA triblock (Figure
13).
The FTIR peaks and unique fingerprint regions were compared to literature values in order to
confirm the correct polymerization occurred with the triblock. Since the polymer itself was not novel
literature was able to provide insist on the fingerprint region and the key peaks found. The addition of the
peak around 1700 cm-1 in the mPEG-PCL-mPEG sample indicates the presence of the esters in the
middle, PCL segment. The additional peak around 2900 cm-1 on the traditional broad OH peak is
attributed to CH stretching found in the mPEG segments of both polymers and the addition of the small
peak in the fingerprint region at 1100cm-1 is the ether stretching.16 With the unique FTIR spectra’s
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compared to literature values, the identity of the polymer could be confirmed as mPEG-PCL-mPEG and
further experiments ensued.
With polymer successfully synthesized the next step was to pursue the synthesis of the
nanoparticles. The nanoparticle, drug delivery system used was a single layer micelle made from a
triblock polymer capable of dissociation at a specific pH value of 5.4. Triblock, biodegradable micelles
made from mPEG-PCL-mPEG were synthesized, characterized and drug-loaded with ribavirin, Nile red,
and 6-azauridne. The drugs ribavirin and 6-azauridine were selected for their previous success in
literature as possible antivirals against common blood borne pathogens like Zika and dengue virus.10,3436,42-44

Since the system itself was novel the idea was to start out with known drug candidates to be able to

ensure effectiveness of the drug delivery system. The other molecule Nile red was selected as a tracking
dye and therefore yielded the capability of future experiments aimed at analyzing the cellular uptake of
the micelles.
To synthesize the drug-loaded micelles, first polymer-based micelles without any drugs loaded
into them called blanks were synthesized. The concept of turning polymers into micelles is not novel and
thus various methods could have been pursued. For the purpose of creating a drug carrier that was
biocompatible the method selected was thermal induced self-assembly. This method ensured the micelles
were not suspended in a toxic solvent but rather were suspended in and drug loaded in ultra-pure DI
water. Once formed, the blank micelles were checked to ensure micelle formation via UV-vis
spectroscopy and dynamic light scattering before moving on to drug loading. In order to determine the
corresponding amount of required drug to efficiently drug-load the micelles, topological polar surface
area (TPSA) was run on the three molecules ribavirin, Nile red, and 6-azauridine.
Ribavirin’s TPSA was calculated via the software, Molinspiration Cheminformatics and was
determined to be 143.73 Å².36 The calculated TPSA was compared directly to a known cancer drug,
doxorubicin, in which the drug loading capacity was known for the triblock micelles.32,33,36 Since
doxorubicin’s TPSA was 206 Å² and had a known drug loading capacity of 3 mg per 20 mg of triblock
polymer, ribavirin’s drug loading capacity could be determined to load at a rate of 4.5 mg per 20 mg of
triblock polymer 36. The blanks were used in drug-loading with the drug, ribavirin, and the loaded
micelles were characterized using UV-vis spectroscopy and dynamic light scattering. Results showed the
trend that ribavirin-loaded micelles, when compared to the blank micelles, are slightly shifted. The loaded
micelles have a broad peak that occurs around 270 nm, while the blanks are slightly red-shifted and have
a broad peak around 300 nm (Figure 14). The slight shift in these peaks is attributed to the loading of
ribavirin, which is not found solely inside the micelle. Some of the drug can become trapped in the
polymer layer, causing the peak to shift closer to the peak of the drug, ribavirin. The ribavirin-loaded
micelles were further characterized to ensure the overall quality. In order to predict major repulsive or
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attractive forces that could become an issue once the micelles are tested in vitro, the surface charge of
these micelles was measured via zeta potential and the average diameter of the micelle suspension was
calculated through dynamic light scattering. The zeta potential of the mPEG-PCL-mPEG, ribavirinloaded micelles is -3.74 ± 0.675 mV (Figure 15) while the average diameter of the micelles is 63.44 ±
8.615 nm (Figure 16). Since the surface charge of the micelles is within ±30 mV, it can be assumed that
the micelles will not experience any attractive or repulsive forces when tested in vitro.46 The micelles’
average diameter, which is consistently around 60 nm, is also consistent with literature’s reported value of
58 nm.23 With the near-neutral surface charge and the small average diameter below the upper limits of
cellular uptake the drug loaded micelles meet all requirements noted in literature to be able to successfully
preform the task of drug deliver to their target.
With drug loading and characterization successful, the ribavirin-loaded micelles were next tested
to ensure pH-responsive dissociation and drug release. Up until this point the micelles had only been
tested to ensure characterization in order to meet the theoretical requirements to be able to deliver an
antiviral to its target. Before assessing drug release, standards of ribavirin comprised of 10 different
concentrations, each dissolved in 3.5 mL of DI water, were analyzed using UV-vis spectroscopy (Figure
17). The samples indicated a linear separation of absorbances at 270 nm, as seen in the graph inlet on
Figure 17, which was used to create a standard of drug concentration in mg/mL compared to their
respected absorbances (Figure 18). The kinetics study assessing the release of ribavirin from the triblock
micelle comprised of mPEG-PCL-mPEG polymers consisted of a 1.5 mL sample of ribavirin-loaded
mPEG-PCL-mPEG micelles that was initially characterized to ensure proper formation prior to
assessment of micellar dissociation and subsequent drug release at pH 5.49 by drop wise addition of PBS.
Once micellar dissociation started, the samples were assessed by UV-visual spectroscopy in the
wavelength range from 800 nm-200 nm, coupled with dynamic light scattering to monitor the release of
the drug (Figures 19 & 20, Table 2). The first UV-vis spectrum obtained after micelle dissociation was
labeled “run 1” and occurred at the 6 minute mark. This was the quickest the sample could be pH
corrected via dropwise addition, measured and analyzed in the instrument. The UV-vis spectrum obtained
for this sample was compared to the spectrum of the initial drug loaded micelles, as indicated by run 0,
and showed a complete release of the ribavirin by 6 minutes post-pH decrease to 5.49. The release of the
drug yielded a slight blue-shift in the spectrum which was consistent in the kinetics study for the next 11
data points. The initial average diameter of the drug-loaded micelles determined from run 0 was 58.94 ±
6.051 nm while runs 1-12 showed an increase in instability indicated through the increase in standard
deviation. The increase in instability is consistent with the concept of dissociation, since as the micelles
begin to break apart their average diameter fluctuated, leading to the varying standard deviations. Since
the difference in absorbance on the UV-vis spectra from runs 1-12 was minimum while the average
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diameter varied, it is determined that this information collectively shows the occurrence of successful
micelle dissociation and drug release. Now that the micelles had proven capable of the complete
dissociation mediated by pH thus releasing the pay load, the other two molecules Nile red and 6azauridine could be drug loaded.
The triblock mPEG-PCL-mPEG micelles were next loaded with the fluorescent dye, Nile red.
Nile red-loaded micelles were synthesized and characterized similarly to their ribavirin-loaded micelle
counterparts previously described. Nile red’s TPSA was also calculated via the software Molinspiration
Cheminformatics, and was determined to be 46.34 Å².36 Nile red’s TPSA was directly compared to the
previously determined doxorubicin’s TPSA and drug loading capacity of 206 Å² and 3 mg per 20 mg of
triblock polymer.36 From the comparison, Nile red was able to drug load 0.5 mg per 20 mg of triblock
polymer. The Nile red-based sample was characterized once formed using UV-vis spectroscopy coupled
with dynamic light scattering in order to ensure that the particles were loaded correctly and similar in size
to the ribavirin loaded micelles (Figures 21 & 22). The average diameter of the Nile red-loaded micelles
was determined to be 84.73 ± 54.16 nm using dynamic light scattering, which was larger than the
ribavirin-loaded micelles yet still within acceptable range to ensure the ability of cellular uptake.47 The
Nile red loaded micelles still met the theoretical requirements and were capable of pH mediated drug
release like their ribavirin counterparts.
With both Nile red and ribavirin both successful in drug loading the last molecule 6-azauridine
was ready to be drug loaded. Triblock, mPEG-PCL-mPEG blank micelles were synthesized once again
for drug loading and characterized. However instead of loading with ribavirin or Nile red, they were
loaded with the other drug candidate, 6-azauridine. The 6-azauridine’s TPSA was also calculated via the
software Molinspiration Cheminformatics and determined to be 132 Å².36 This was compared back to
doxorubicin’s TPSA of 206 Å² along with doxorubicin’s drug loading capacity of 3 mg per 20 mg of
triblock polymer.36 For 6-azauridine, the drug loading capacity was 4.9mg per 20mg of triblock polymer.
The 6-azauridine-loaded sample was characterized using UV-vis spectroscopy along with dynamic light
scattering in order to ensure that the micelles were fully formed and similar to the original ribavirinloaded micelles previously characterized (Figures 23 & 24). The peak absorbance on the UV-vis spectra
for the 6-azauridine-loaded micelles was slightly red-shifted and was closer to 300 nm while the average
diameter of the 6-azauridine-loaded triblock micelles was determined to be 55.25 ± 23.90 nm using
dynamic light scattering. The slight red-shift was attributed to the loading of 6-azaurdine which is not
found solely inside the micelle and thus causes the slight absorbance shift. The 6-azauridine micelles’
average diameter was once again similar to ribavirin-loaded micelles, and also well under the expected
size limit for cellular uptake.23,47 With the micelles loaded with 6-azauridine meeting the theoretical
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limitations for drug loading and cellular uptake the drug delivery system had the last main piece ready to
be further tested for drug release.
After the 6-azauridine-loaded micelles were characterized using UV-vis spectroscopy along with
dynamic light scattering and found to have similar characteristics to ribavirin-loaded micelles, the 6azauridine-loaded micelles were tested in a similar kinetic method in order to ensure similar drug release
via pH correction. To test this the 6-azauridine-loaded micelles were corrected to a pH of 5.74 which is
past their documented pH dissociation value and the dissociation was monitored using UV-visual
spectroscopy along with dynamic light scattering to ensure proper release of the drug (Figures 25 & 26).
The absorbance decreased across the spectra, which is consistent with drug release as also indicated by
the ribavirin-loaded micelles. The average diameter of the 6-azauridine-loaded mPEG-PCL-mPEG
micelles following dissociation increased to a size of 76.88 ± 17.16 nm, as judged by dynamic light
scattering. Similarly, this increase in average diameter matches the increase noted in the ribavirin-loaded
micelles and is consistent with the idea that as the micelles begin to dissociate, they swell and/or collapse,
causing a wider range of average diameters.
In a fashion similar to the construction and assessment of the ribavirin standards, 7 concentrations
of 6-azauridine standards were produced. Varying concentrations of the drug, 6-azauridine, were
dissolved in DI water to achieve specific concentrations of 6-azauridine, in g/mL, and the samples were
used to collect UV-vis spectra to determine the best wavelength for a linear standard. The samples
indicated a linear separation at 317 nm and therefore the absorbance at 317 nm was used to relate drug
release of 6-azauridine in g/mL (Figures 27 & 28) This method mirrored the previous method and set the
ground work for future experiments possible looking into precise drug release amounts.
The micelles themselves follow some basic trends when working with them as a whole. First,
there is a notable shift when drug loading the blank micelles. The blanks when compared to the drug
loaded are consistently red shifted. This phenomenon is attributed to imperfect drug loading of the
micelles since when forming, the drug of choice does not perfectly load into the center and small amounts
are trapped in the polymer layer. These small amounts of drugs have different light absorbances which
shift the overall spectra slightly. The pattern of having a shift on the UV-vis spectra were consistent
throughout the three options but the shift itself is dependent on the drug that is loaded. Another pattern
noted though out the three options is that blank micelles and their dissociated counterparts are not overly
stable in nature. The polymer based micelles prefer to be stabilized with a drug loaded into it and while
the core is not bonded to the polymer in any fashion there are weak intermolecular forces that stabilized
the micelles making them more likely to be stable over long periods of time. The evidence for their lack
of stability is clear throughout the dynamic light scattering data for each set of micelles. The average
diameter data shows an increase in standard deviation that is consistent throughout the samples that do not
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have anything loaded into their core while the micelles that are stabilized with a molecule loaded into it
yield relatively small deviation and tend to be more consistent.
The trends noted laid the foundation for a drug delivery system that is tunable to meet the
demands of a wide range of applications against viruses. While the triblock, mPEG-PCL-mPEG polymer
was specifically utilized to meet the pH dissociation of 5.4, there are endless options in coblock polymers
that can be explored using this foundation of experiments to determine the capability of the system.
Polymers can be selected for varying pH dissociation, time release, ability to be functionalized or even
varied in size to meet the demands of loading larger/smaller or charged molecules. 16,19,23-27 The
nanoparticle system is not defined by a single polymer, target or payload making it the launch point for a
drug delivery system that is applicable for today’s needs.
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CHAPTER 7
CONCLUSION AND FUTURE OUTLOOK

The way scientists approach viruses has evolved greatly since the initial discovery of yellow fever
virus over 100 years ago. As technology boomed, detection of infectious agents along with their
identification paved the way for a new classification system able to adequately distinguish and categorize
the various viruses discovered. Viruses could be grouped together based on similar properties and thus
scientists began to research new methods against them accordingly. The recent increases in global
temperature paired with the rise in travel has created new environments for common vectors such as the
Aedes mosquitoes that now can thrive in a larger portions of the world. In Georgia, the increase in global
temperature and urban travel has resulted in the conformation of the presence of Aedes mosquitoes in
Georgia as early as 2016, specifically the Aedes aegypti.6 The emergence of these mosquitoes has come
with the challenge of dealing with viral transmission since mosquito-borne viruses of the Flaviviridae
family, such as Zika virus and dengue, often utilize the Ades mosquitoes for transmittance.4,5 With no
FDA approved therapies or vaccines against mosquito-borne pathogens, treatment and care for people
infected with viruses like Zika and dengue revolve around a doctor’s ability to offer supportive care.9,11,12
The need for research against selective therapies to target blood-borne pathogens is rapidly growing. The
recent explosion of bio-based polymer research has become an unusual answer to the challenge of
creating highly selective drug delivery methods.20 By combining pH sensitive, biocompatible polymers
with common drugs known to have some antiviral properties, scientists are able to create drug carriers
that release their cargo at locations in the cell that are key in the life cycle of specific viruses based on the
cells’ micro pH (Table 1). Targeting cellular micro pH values with polymers that dissociate at a specific
pH allow for creation of a drug delivery system that can be modified depending on the target subcellular
location.
With the target location of this thesis project revolving around the late endosome, a pH sensitive,
drug delivery system needed to be created that could carry specific antivirals to the desired subcellular
location and release them to interfere with the replication of the viruses’ life cycle. The biocompatible
triblock polymer, mPEG-PCL-mPEG was selected based on its ability to form micelles and have a
dissociation point of pH 5.4, thus making it a suitable drug delivery method that had the potential to target
the late endosome. These micelles could be synthesized using methods that invoked minimal or no undue
toxicity to the cells via thermal induced self-assembly and drug-loading.23-27 The drug-loaded micelles
from the triblock polymer were synthesized and then seamlessly characterized to ensure quality and
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overall uniformity across the two drugs analyzed: ribavirin and 6-azauridine, along with the fluorescent
dye, Nile red. The micelles were kept below the maximum allowable size to be easily uptaken by cells
and studied to ensure proper release of their antiviral cargo at the appropriate pH change.16,17,47 Successful
formation, encapsulation and dissociation of the micelles, was monitored via UV-Vis spectroscopy and
dynamic light scattering. Drug release of the micelles was compared to their corresponding drug standard
to determine full dissociation and kinetics of the polymer dissociation.
With preliminary data to support the successful synthesis of ribavirin-loaded mPEG-PCL-mPEG
micelles, future work will largely focus on other drug opportunities and testing the concepts in vitro. The
concept of targeting cellular locations for drug release utilizing the specific pH dissociation of the
polymer-based micelles, thus resulting in virus suppression, is ready to be investigated fully via in vitro
studies. The micelles will be tested against JEG-3 (placental cancer cells), HMC3 (microglia cells), and
Huh7 cells (liver cells) with and without infection. The cell lines JEG-3 and HMC3 cells will handle
infection with Zika virus studies while Huh7 cells will be infected with dengue virus. Final analysis of the
system will be geared towards infection of A129 mice which are immunodeficient mice that can be
utilized in virus studies for dengue and Zika virus pathogenesis.
Viral infection of various cells to determine the suppression ability of mPEG-PCL-mPEG must
be carefully inspected with and without drug-loaded micelles. The overall toxicity of the micelles which
has been reported in a general manner will have to be addressed using toxicity assays such as MTT assays
to ensure the safety of the system. Further experiments aimed at targeting organelles in the cell with
peptides such as the -KDEL peptide can also be pursued to gain a complete picture of how the drug
delivery system works. It should also be noted that this is the ground work for a system that is tunable in
order to fit numerous antiviral candidates along with variances in coblock polymers in order to target
different micro pH’s using micelles that have other dissociation points. The possibilities of the
biocompatible coblock drug delivery system are not limited to mPEG-PCL-mPEG and the two antivirals;
ribavirin and 6-azauridine, but rather is just beginning with the previous work acting as a foundation for
further investigations to spring fourth from.
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